Melanoma-associated antigen A1 and A3 as new candidate of diagnostic for non-small cell lung cancer

Isnin Anam Marhana, Isnin and Muhammad Amin, Muhammad and Gondo Mastutik, Gondo and Oski Illiandri, Oski Melanoma-associated antigen A1 and A3 as new candidate of diagnostic for non-small cell lung cancer. Journal of Advanced Pharmacy Education & Research [JAPER], 11 (2). pp. 1-4. ISSN ISSN-2249-3379

[img] Text (Artikel)
C09 Artikel Melanoma-associated antigen.pdf

Download (4MB)
[img] Text (Laik Etik)
C09 Etik Melanoma-associated antigen.pdf

Download (286kB)
[img] Text (Kualitas Karil & Kesesuaian Bidang Ilmu)
C09 PAK 1.pdf

Download (334kB)
[img] Text (Turnitin)
C09 Turnitin Melanoma-associated antigen.pdf

Download (1MB)
Official URL: https://japer.in/article/melanoma-associated-antig...

Abstract

Abstract The early diagnosis of lung cancer has long been an interesting field for early treatment of the disease. Many diagnostic methods use specific tumor antigens for the diagnosis of lung cancer with low to medium specificity and sensitivity. Recently, melanoma-associated antigen (MAGE) A1 and A3 detection has been emerged as a new tool for lung cancer diagnosis and can be a promising tool in the future. However, it still needs to be investigated to measure the sensitivity and specificity. This research is an analytic observational study conducted at Dr. Soetomo Hospital Surabaya. The population of the study was all patients diagnosed with suspected lung cancer. The research sample was 100 patients’ biopsy samples of lung cancer patients who underwent a core biopsy (CB), bronchoalveolar lavage (BAL), and forceps biopsy (FB) (31 core biopsy, 37 BAL, and 32 forceps biopsy). The sample was taken by histopathology and the expression of MAGE A1 and A2 was measured. The results were analyzed using the Chi-Square Test using SPSS for Mac Version 20.00. Histopathologic results on CB, BAL, and FB showed that 37 patients were positive for carcinoma (47.7%), with the majority of adenocarcinoma (31.6%) and the results of the PA CB, the sensitivity value was 30.43% and the specificity value was 75.00%. In conclusion, the examination of the tumor antigen MAGE A1 and A3 can be used as a new candidate for lung cancer diagnosis in the future.

Item Type: Article
Subjects: R Medicine > R Medicine (General) > R5-920 Medicine (General)
Divisions: 01. Fakultas Kedokteran > Patologi Anatomi
Creators:
CreatorsNIM
Isnin Anam Marhana, IsninUNSPECIFIED
Muhammad Amin, MuhammadNIDN8804680018
Gondo Mastutik, GondoNIDN0027067304
Oski Illiandri, OskiUNSPECIFIED
Depositing User: arys fk
Date Deposited: 01 Apr 2023 05:03
Last Modified: 01 Apr 2023 05:03
URI: http://repository.unair.ac.id/id/eprint/121611
Sosial Share:

Actions (login required)

View Item View Item